Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study.

about

Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study.

Item

http://www.wikidata.org/entity/Q40223007

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Herpes Simplex Virus Type 2 Ac ...... m the ACTG A5175 PEARLS Study.

@en

type

Item

label

Herpes Simplex Virus Type 2 Ac ...... m the ACTG A5175 PEARLS Study.

@en

prefLabel

Herpes Simplex Virus Type 2 Ac ...... m the ACTG A5175 PEARLS Study.

@en

P1476

Herpes Simplex Virus Type 2 Ac ...... m the ACTG A5175 PEARLS Study.

@en

P2093

ACTG PEARLS/A5175 Team

http://www.w3.org/2001/XMLSchema#string

Anne Cent

http://www.w3.org/2001/XMLSchema#string

Breno Santos

http://www.w3.org/2001/XMLSchema#string

Cynthia Riviere

http://www.w3.org/2001/XMLSchema#string

James Hakim

http://www.w3.org/2001/XMLSchema#string

Jared M Baeten

http://www.w3.org/2001/XMLSchema#string

Jorge Sanchez

http://www.w3.org/2001/XMLSchema#string

Khuanchai Supparatpinyo

http://www.w3.org/2001/XMLSchema#string

Mina C Hosseinipour

http://www.w3.org/2001/XMLSchema#string

Mulinda Nyirenda

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication

Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera

Infectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventions

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men

Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial

Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.

Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans

P304

907-910

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIX029

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

215

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28453835

http://www.w3.org/2001/XMLSchema#string

P932

5406847

http://www.w3.org/2001/XMLSchema#string